These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20085496)

  • 21. Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
    Mohammed AF; Andrei G; Hayallah AM; Abdel-Moty SG; Snoeck R; Simons C
    Bioorg Med Chem; 2019 Mar; 27(6):1023-1033. PubMed ID: 30738653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand.
    Dunne EF; Whitehead S; Sternberg M; Thepamnuay S; Leelawiwat W; McNicholl JM; Sumanapun S; Tappero JW; Siriprapasiri T; Markowitz L
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):77-83. PubMed ID: 18667923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
    Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
    PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
    Kriesel JD; Spruance SL; Prichard M; Parker JN; Kern ER
    J Infect Dis; 2005 Jul; 192(1):156-61. PubMed ID: 15942905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L;
    N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
    Andersen-Nissen E; Chang JT; Thomas KK; Adams D; Celum C; Sanchez J; Coombs RW; McElrath MJ; Baeten JM
    Sex Transm Dis; 2016 Dec; 43(12):761-764. PubMed ID: 27832025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
    Mayaud P; Legoff J; Weiss HA; Grésenguet G; Nzambi K; Bouhlal H; Frost E; Pépin J; Malkin JE; Hayes RJ; Mabey DC; Bélec L;
    J Infect Dis; 2009 Jul; 200(2):216-26. PubMed ID: 19530940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Chibo D; Mijch A; Doherty R; Birch C
    J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
    Fuchs J; Celum C; Wang J; Hughes J; Sanchez J; Cowan F; Reid S; Delany-Moretlwe S; Corey L; Wald A;
    J Infect Dis; 2010 Apr; 201(8):1164-8. PubMed ID: 20214474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient.
    Cury K; Valin N; Gozlan J; Jacquier I; Boutolleau D; Guegan S; Flejou JF; Girard PM
    Sex Transm Dis; 2010 Feb; 37(2):126-8. PubMed ID: 19858782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.
    Reyes M; Shaik NS; Graber JM; Nisenbaum R; Wetherall NT; Fukuda K; Reeves WC;
    Arch Intern Med; 2003 Jan; 163(1):76-80. PubMed ID: 12523920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
    Zuckerman RA; Lucchetti A; Whittington WL; Sánchez J; Coombs RW; Magaret A; Wald A; Corey L; Celum C
    AIDS; 2009 Feb; 23(4):479-83. PubMed ID: 19169140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
    Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
    Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.